| Particulars |
| Company Name |
Concord Biotech Ltd |
| Face Value |
1 |
| BSE Code |
543960 |
| Year End |
202503 |
| Full Year |
| Equity (Rs in Cr.) |
10.46 |
| B.V. Rs |
174.50 |
| Sales Rs in Cr. |
1,200.09 |
| NP Rs in Cr. |
356.39 |
| NP Var% |
21.00 |
| Div% |
875.00 |
| CPS Rs |
39.30 |
| EPS Rs |
34.10 |
| Traded Value(Rs in Lakhs) |
18,170.39 |
| 52 Week High |
2,150.00 |
| 52 Week Low |
1,057.00 |
| Price BSE |
1,219.00 |
| Price NSE |
1,231.00 |
| Market Capital(Rs in Cr.) |
12,751.15 |
| P/C Ratio |
31.00 |
| P/E Ratio |
35.80 |
| Price Vs.BV |
6.99 |
| Latest Quarter |
| Year End |
202512 |
| Sales Rs in Cr. |
278.13 |
| NP Rs in Cr. |
70.24 |
| NP Var % |
-5.00 |
| Trailing Twelve Months |
| Year End |
202512 |
| Sales |
1,085.75 |
| OPM |
42.50 |
| NP |
328.71 |
| NP Var% |
-3.23 |
| EPS |
30.36 |
| PE |
40.15 |
|